Ann Colosia, PhD

Associate Director, Market Access and Outcomes Strategy

PhD, Molecular Physiology and Biophysics
BS, General Biology
Vanderbilt University, Nashville, TN

Ann Colosia, PhD, is an Associate Director in the Market Access and Outcomes Strategy group. She has more than 18 years of experience in communicating pharmaceutical drug value to payers and physicians. She has experience conducting literature reviews, including systematic literature reviews, and developing product value dossiers and Academy of Managed Care Pharmacy (AMCP) dossiers. Before joining RTI-HS, she developed science and business materials with an educational focus for sales training programs. Prior to beginning her career in health care communications, her laboratory research dealt with glucoregulatory mechanisms affected by diabetes and autoimmune mechanisms causing autoantibody development. Dr. Colosia’s writing experience includes the therapeutic areas of diabetes, cancers, gastrointestinal diseases, hypercholesterolemia, cardiovascular disease, Parkinson’s disease, pulmonary diseases, hematoproliferative disorders, and autoimmune diseases.